Galectin-1 in Obesity and Type 2 Diabetes by Emanuel Fryk, Vagner R. R. Silva, Per-Anders Jansson

Get full text

The role of the platelet pool of Plasminogen Activator Inhibitor-1 in well-controlled type 2 diabetes patients. by Karin Mossberg, Josefin Olausson, Emanuel Fryk, Sverker Jern, Per-Anders Jansson, Helén Brogren

Get full text

Cardiorespiratory fitness and the association with galectin-1 in middle-aged individuals. by Daniel Arvidsson, Vagner Ramon Rodrigues Silva, Örjan Ekblom, Elin Ekblom-Bak, Emanuel Fryk, Per-Anders Jansson, Mats Börjesson

Get full text

Galectin-1 is inversely associated with type 2 diabetes independently of obesity – A SCAPIS pilot study by Emanuel Fryk, Lena Strindberg, Annika Lundqvist, Mikael Sandstedt, Lennart Bergfeldt, Lillemor Mattsson Hultén, Göran Bergström, Per-Anders Jansson

Get full text